These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8939386)

  • 1. Usefulness of flow cytometric detection of cell surface interleukin-6 receptors in human myeloma cell lines.
    Chen YH; Feng XX; Hagen K
    Clin Lab Haematol; 1996 Sep; 18(3):161-9. PubMed ID: 8939386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
    Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
    Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal anti-human IL-6 receptor antibody inhibits the proliferation of human myeloma cells.
    Huang YW; Vitetta ES
    Hybridoma; 1993 Oct; 12(5):621-30. PubMed ID: 8300137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategies.
    Villunger A; Egle A; Kos M; Hittmair A; Maly K; Greil R
    Int J Cancer; 1996 Feb; 65(4):498-505. PubMed ID: 8621234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Koishihara Y
    Jpn J Cancer Res; 1994 Sep; 85(9):958-65. PubMed ID: 7961126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
    Lasfar A; Wietzerbin J; Billard C
    Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
    Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
    Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
    Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
    Gaillard JP; Liautard J; Klein B; Brochier J
    Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
    Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
    Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
    Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G
    Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
    Levy Y; Labaume S; Colombel M; Brouet JC
    Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma.
    Kyrtsonis MC; Dedoussis G; Zervas C; Perifanis V; Baxevanis C; Stamatelou M; Maniatis A
    Br J Haematol; 1996 May; 93(2):398-400. PubMed ID: 8639436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro.
    Nakajima T; Yamamoto S; Cheng M; Yasukawa K; Hirano T; Kishimoto T; Tokunaga T; Honda M
    Jpn J Cancer Res; 1992 Apr; 83(4):373-8. PubMed ID: 1506271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of IL-6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL-6 receptors by Epstein-Barr virus in vitro.
    Tomeczkowski J; zur Stadt U; Reiter A; Welte K; Sykora KW
    Br J Haematol; 1997 May; 97(2):400-8. PubMed ID: 9163607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells.
    Schwabe M; Zhao J; Kung HF
    J Biol Chem; 1994 Mar; 269(10):7201-9. PubMed ID: 8125932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
    Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
    Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
    Keller ET; Ershler WB
    J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism.
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Fujita N; Tsuchiya M; Koishihara Y; Ohsugi Y; Nakagawa M
    Leukemia; 1995 Apr; 9(4):711-8. PubMed ID: 7723407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer.
    Matsuzaki N; Neki R; Sawai K; Shimoya K; Okada T; Sakata M; Saji F; Koishihara Y; Ida N
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2912-7. PubMed ID: 7559874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.